Substituted &agr;, &bgr;-anellated butyrolactones

US6723718B2 · kind B2 · utility

Assignee

• BAYER HEALTHCARE LLC · DE

Inventors

• Andreas Stolle · Milford, US
• Horst-Peter Antonicek · Bensberg, DE
• Stephen Lensky · Gützkow, DE
• Arnd Voerste
• Thomas Müller · Bonn, DE
• Jorg Baumgarten · Wuppertal, DE
• Karsten von dem Bruch · Leverkusen, DE
• Gerhard Müller · Krefeld, DE
• Udo Stropp · Haan, DE
• Ervin Horvath · Leverkusen, DE
• Jean De Vry · Stolberg, DE
• Rudy Schreiber · Menlo Park, US

Key dates

• Filing date: Jul 25, 2002
• Grant date: Apr 20, 2004
• Expiry date: Aug 3, 2022

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/12
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The present invention relates to novel substituted &agr;,&bgr;-fused butyrolactones, to processes for their preparation and to their use for the prevention and/or treatment of disorders caused by hyper- or hypofunction of the glutamatergic system, in particular of cerebral ischaemias, craniocerebral trauma, states of pain or CNS-mediated spasms.